Table 1.

Average survival of two cyclic stages of Leishmania parasites treated with different doses of imatinib and different periods of time presented as number and mean±standard deviation

Group (µg/ml)	Time (h)	Promastigotes	Amastigotes	P
Imatinib 25	24	20.7±0.8	67±3.3	<0.001
	48	16±0.35	53.5±9.5
	72	9.3±0.52	35.6±6.2
Imatinib 50	24	13.8±0.83	53.3±8.8	<0.001
	48	10.7±0.7	43±12.9
	72	6.5±0.5	28.5±3.5
Imatinib 100	24	6.9±0.76	47±10	<0.001
	48	4.6±0.62	35.7±6.2
	72	2.33±0.7	21.4±3.6
Amphotericin B 25	24	1.13±0.11	50±8.8	<0.001
	48	0.8±0.6	28.5±3.5
	72	0.6±0.1	15.4±2.1